🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study of the safety of open-label SPI-1005 400 mg BID treatment in adults w...
Status
Active Not Recruiting
Location
The House Institute
Start Date
2025-10-29
Trial ID
NCT06859788
Treatments Being Tested
This experimental medicine study will examine the effects of a brief period...
Status
Unknown
Location
Neurosciences Building, Dept. Psychiatry, Warneford Hospital
Start Date
2021-04-22
Trial ID
NCT05117710
This study will evaluate the safety, efficacy, and Pharmacokinetics (PK) of...
Status
Completed
Location
Ccent/Cccr
Start Date
2017-09-28
Trial ID
NCT03325790
Treatments Being Tested
The study is a randomized, double-blind, placebo-controlled, dose escalatio...
Status
Completed
Location
Yale University
Start Date
2021-08-27
Trial ID
NCT04483973
The study is a randomized, double-blind, placebo-controlled, dose escalatio...
Status
Enrolling By Invitation
Location
Yale University
Start Date
2021-10-12
Trial ID
NCT04484025
Chemotherapy treatment with platinum based agents is well noted to cause ot...
Status
Withdrawn
Location
VA Puget Sound Health Care
Start Date
2026-06
Trial ID
NCT01451853
Treatments Being Tested
The goal of this clinical trial is to learn about the effects of drug SPI-1...
Status
Recruiting
Location
University of Iowa
Start Date
2026-12
Trial ID
NCT06340633
This study will evaluate the safety and efficacy of three dose levels of SP...
Status
Completed
Location
House Clinic
Start Date
2015-12
Trial ID
NCT02603081
Treatments Being Tested
The primary objective of this study is to determine the safety and efficacy...
Status
Completed
Location
Medical University of South Carolina
Start Date
2017-07-21
Trial ID
NCT02819856
SPI-1005 is a novel oral drug that contains a glutathione peroxidase mimeti...
Status
Withdrawn
Location
University of Miami
Start Date
2026-06
Trial ID
NCT02779192
Treatments Being Tested